logo
Select company
Select metric
-157.14%Operating Cash Flow Margin
VS
Market
10
Sector
33
Industry
61
History
50
$ 2.12Close
$ 1.86 - $ 7.1 52-Week Range
Ticker Information

Ticker

INM

Company Name

INMED PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

INMED PHARMACEUTICALS INC - Operating Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

INM - OCF % Historical data
DateNet Cash Flow - OperationsOperating Cash Flow MarginRevenues
6/30/2025$ -7.77M-157.14%$ 4.94M
3/31/2025$ -7.02M-142.61%$ 4.92M
12/31/2024$ -7.29M-150.92%$ 4.83M
9/30/2024$ -6.64M-133.83%$ 4.96M
6/30/2024$ -6.99M-151.94%$ 4.6M
3/31/2024$ -6.61M-117.58%$ 5.63M
12/31/2023$ -6.34M-115.49%$ 5.49M
9/30/2023$ -7.2M-152.69%$ 4.72M
6/30/2023$ -7.28M-176.11%$ 4.14M
3/31/2023$ -10.67M-456.24%$ 2.34M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • INMED PHARMACEUTICALS INC's latest trailing twelve months (TTM) OCF % stands at 0%.
  • Over the past 5 years, INMED PHARMACEUTICALS INC's average OCF % has been -822.56%.
  • The median OCF % for INMED PHARMACEUTICALS INC during this period was -157.14%
  • INMED PHARMACEUTICALS INC reached its highest OCF % over the past 5 years at -115.49%.
  • The lowest OCF % recorded by INMED PHARMACEUTICALS INC in the same timeframe -4830.56%

INMED PHARMACEUTICALS INC's OCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

OCF % Benchmarks
CompanyOCF %
NBY : NOVABAY PHARMACEUTICALS INC -154.69%XBIO : XENETIC BIOSCIENCES INC -102.96%SPRB : SPRUCE BIOSCIENCES INC -3961.12%CPHI : CHINA PHARMA HOLDINGS INC 9.66%ONCO : ONCONETIX INC -412.54%SXTP : 60 DEGREES PHARMACEUTICALS INC -748.71%BNBX : APPLIED DNA SCIENCES INC -381.39%ADTX : ADITXT INC -187614.69%CDT : CONDUIT PHARMACEUTICALS INC -GTBP : GT BIOPHARMA INC -

Definition of Operating Cash Flow Margin

[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
CF - Operations / Revenues
(=) OCF %
OCF % for INMED PHARMACEUTICALS INC is calculated as follows: CF - Operations [ $ -9.79M ] / Revenues [ $ 0 ]
(=) OCF % [ 0% ]

INM - Operating Cash Flow Margin, Last 5 years

-4830.56%

Minimum

Dec 31, 2021

-115.49%

Maximum

Dec 31, 2023

-822.56%

Average

-157.14%

Median

OCF % Benchmark Analysis

The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.35% with a standard deviation of 21.14%.
The following table provides additional summary stats:
OCF % in the Market:
filtered constituents3.25K
min-57.27%
max78.12%
average14.35%
median12.67%
std21.14%